Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,170,439
+$3,130,428 QoQ
Shares Held
349,732
+66.6% QoQ
Ownership
0.586%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 169 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Derivatives in TYRA
reported options exposure · as of Mar 31, 2023CallValue
$642,800
CallShares
40,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. TYRA ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in TYRA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,170,439 | 349,732 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,040,011 | 209,922 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,007,169 | 38,310 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,879,121 | 134,319 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,569,293 | 372,967 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $776,744 | 83,521 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $919,580 | 66,157 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,277,838 | 54,353 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $791,776 | 49,517 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $541,724 | 33,032 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $306,333 | 22,118 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $305,197 | 22,164 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $347,615 | 20,412 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $642,800 | 40,000 | Call | Defined | 2023-05-12 | |
| 2023-03-31 | $289,436 | 18,011 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $159,310 | 20,962 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $121,221 | 13,791 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $140,990 | 19,719 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $686,148 | 64,126 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $80,550 | 5,725 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $15,566 | 885 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||